The (1,3)-β-D-glucan use for invasive candidiasis diagnosis in non-neutropenic critically ill patients: a prospective cohort study
The major benefit of BDG test in intensive care seems to lie in its NPV allowing to roll out the invasive candidiasis diagnosis then withhold or interrupt antifungal therapy.
Authors
- Ahlem Trifi (ORCID: https://orcid.org/0000-0001-5088-2310)
- Eya Seghir
- Aicha Kallel
- Asma Mehdi
- Sami Abdellatif
- Badis Tlili (ORCID: https://orcid.org/0000-0003-1299-1422)
- K. Kallel
- Salah Ben Lakhal
- Lynda Messaoued
Institutions
- Hôpital Farhat Hached (TN)
- Tunis El Manar University (TN)
Publication Details
- Journal
- La Tunisie Médicale
- Published
- 2024-12-01
- DOI
- https://doi.org/10.62438/tunismed.v102i12.5254
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00